Trial Details
Not RecruitingBasic Information
| Clinical ID | c5193 |
|---|---|
| Identifier | DRKS00013251 |
| Trial Title | Vedolizumab Study with Inflammatory Bowel Disease Patients in Germany - VEDOibd I Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | K50 K51;Crohn disease [regional enteritis];Ulcerative colitis |
| Interventions | Group 1: IBD-patients (age at enrollment 18-80 years) receiving a new treatment with vedolizumab. A former treatment with biologics will be allowed. More than 30% of patients with Vedolizumab therapy will be biologics-naiv.Group 2: IBD-patients (age a |
Participant Information
| Sponsor | CED Service GmbH |
|---|---|
| City | NULL |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | observational |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |